During the past decade, Advanced Urology Centers of New York conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advanced Urology Centers of New York" are "Enteric Hyperoxaluria" (1 trials), "Overactive Bladder" (1 trials), "Prostate Cancer" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Advanced Urology Centers of New York" in a lesser frequency.

Most popular intervention types in "Advanced Urology Centers of New York" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ALLN-177" (1 trials), "Botulinum toxin type A" (1 trials), "Enzalutamide" (1 trials) and "Galeterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Urology Centers of New York" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Advanced Urology Centers of New York". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advanced Urology Centers of New York, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Urology Centers of New York, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".